Match each patient's clinical presentation following a toxic ingestion or medication overdose to the most appropriate initial specific pharmacologic antidote or therapy.
- A 24-year-old man presenting with a respiratory rate of 6/min, pinpoint pupils, and profound lethargy.Intravenous naloxone
- A 35-year-old woman presenting with right upper quadrant pain and an AST level of 4,200 U/L 48 hours after an analgesic overdose.Intravenous N-acetylcysteine
- A 42-year-old man presenting with severe bradycardia, hypotension, and a blood glucose of 55 mg/dL after ingesting his roommate's blood pressure medication.Intravenous glucagon
- A 28-year-old woman presenting with dry flushed skin, dilated pupils, and an ECG showing a QRS duration of 140 msec after an antidepressant overdose.Intravenous sodium bicarbonate
- A 65-year-old man presenting with nausea, yellow-tinted vision, and an ECG showing atrial tachycardia with AV block after a recent dosage increase of his heart failure medication.Intravenous digoxin-specific antibody fragments
Answer
The presentations match their specific antidotes as follows: the patient with opioid toxicity requires naloxone; the patient with acetaminophen hepatotoxicity requires N-acetylcysteine; the patient with beta-blocker overdose requires glucagon; the patient with tricyclic antidepressant cardiotoxicity requires sodium bicarbonate; and the patient with digoxin toxicity requires digoxin-specific antibody fragments.
Each clinical vignette presents a classic toxic ingestion that dictates a specific antidote. Opioid overdose (miosis, respiratory depression) is reversed by naloxone. Acetaminophen overdose (hepatocellular injury) is treated with N-acetylcysteine. Beta-blocker overdose (bradycardia, hypoglycemia) is treated with glucagon. Tricyclic antidepressant overdose (anticholinergic toxicity, QRS widening) is treated with sodium bicarbonate. Digoxin toxicity (visual changes, arrhythmias) is treated with digoxin-specific antibody fragments.
Step-by-Step Solution
Key Concept
Recognition of classic toxidromes and selection of specific, life-saving pharmacologic antidotes.